InsidersTradesSigma
휴네시온 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 휴네시온 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 휴네시온 has logged 2 reports. Market capitalisation: €24.8bn. The latest transaction was reported on 21 April 2026 (Sale). Among the most active insiders: 심재중. All data is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€26,220
2 ops.
Sell Volume
15Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 322 of 28,093 companies
86.8
score / 100
Value96
Quality78
FCF yld24%
Earn yld23%
EV/EBITDA3.7x
ROE12%
Gross mgn48%
Net mgn15%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 21 April 2026
About 휴네시온
휴네시온 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for the medical sector.